JP2019512018A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019512018A5 JP2019512018A5 JP2018560436A JP2018560436A JP2019512018A5 JP 2019512018 A5 JP2019512018 A5 JP 2019512018A5 JP 2018560436 A JP2018560436 A JP 2018560436A JP 2018560436 A JP2018560436 A JP 2018560436A JP 2019512018 A5 JP2019512018 A5 JP 2019512018A5
- Authority
- JP
- Japan
- Prior art keywords
- hom
- composition
- tissue sample
- expression
- level
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022143467A JP7635939B2 (ja) | 2016-02-04 | 2022-09-09 | 炎症性障害の治療及び診断 |
| JP2024153550A JP2024170560A (ja) | 2016-02-04 | 2024-09-06 | 炎症性障害の治療及び診断 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662291271P | 2016-02-04 | 2016-02-04 | |
| US62/291,271 | 2016-02-04 | ||
| PCT/US2017/015775 WO2017136322A1 (en) | 2016-02-04 | 2017-01-31 | Treatment and diagnosis of inflammatory disorders |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022143467A Division JP7635939B2 (ja) | 2016-02-04 | 2022-09-09 | 炎症性障害の治療及び診断 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019512018A JP2019512018A (ja) | 2019-05-09 |
| JP2019512018A5 true JP2019512018A5 (enExample) | 2020-03-12 |
Family
ID=59499992
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018560436A Pending JP2019512018A (ja) | 2016-02-04 | 2017-01-31 | 炎症性障害の治療及び診断 |
| JP2022143467A Active JP7635939B2 (ja) | 2016-02-04 | 2022-09-09 | 炎症性障害の治療及び診断 |
| JP2024153550A Pending JP2024170560A (ja) | 2016-02-04 | 2024-09-06 | 炎症性障害の治療及び診断 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022143467A Active JP7635939B2 (ja) | 2016-02-04 | 2022-09-09 | 炎症性障害の治療及び診断 |
| JP2024153550A Pending JP2024170560A (ja) | 2016-02-04 | 2024-09-06 | 炎症性障害の治療及び診断 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US11268095B2 (enExample) |
| EP (1) | EP3411479A4 (enExample) |
| JP (3) | JP2019512018A (enExample) |
| KR (1) | KR20180109985A (enExample) |
| CN (1) | CN108779461A (enExample) |
| AU (2) | AU2017213744B2 (enExample) |
| CA (1) | CA3013898A1 (enExample) |
| CL (3) | CL2018002097A1 (enExample) |
| IL (2) | IL311968A (enExample) |
| MX (2) | MX2018009542A (enExample) |
| MY (2) | MY203831A (enExample) |
| SG (2) | SG11201806636SA (enExample) |
| WO (1) | WO2017136322A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2017213744B2 (en) | 2016-02-04 | 2023-06-22 | Hong Gao | Treatment and diagnosis of inflammatory disorders |
| EP3952947A4 (en) | 2019-04-11 | 2024-07-03 | Enclear Therapies, Inc. | METHODS FOR IMPROVING CSF AND DEVICES AND SYSTEMS THEREFOR |
| CN111528842B (zh) * | 2020-05-26 | 2023-01-03 | 复嶂环洲生物科技(上海)有限公司 | 基于生理和行为指标的帕金森病症状定量化评估方法 |
| AU2021355470A1 (en) | 2020-09-29 | 2023-06-01 | Enclear Therapies, Inc. | Subarachnoid fluid management method and system |
| AU2022297513A1 (en) * | 2021-06-23 | 2024-01-18 | Enclear Therapies, Inc. | Method of regulating gene expression |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2709309B1 (fr) | 1993-08-25 | 1995-11-10 | Centre Nat Rech Scient | Compositions cellulaires, préparation et utilisations thérapeutiques. |
| US5583153A (en) | 1994-10-06 | 1996-12-10 | Regents Of The University Of California | Use of taxol in the treatment of rheumatoid arthritis |
| US20030035790A1 (en) | 1999-01-15 | 2003-02-20 | Shu-Hsia Chen | Combination therapy for the prevention or treatment of cancer, inflammatory disorders or infectious diseases in a subject |
| EP1222933A1 (en) | 2001-01-15 | 2002-07-17 | Academisch Ziekenhuis Leiden h.o.d.n., Leids Universitair Medisch Centrum | Generation and/or reduction of new lung tissue in an affected lung, by modulation of the Wnt-pathway |
| US20040142325A1 (en) | 2001-09-14 | 2004-07-22 | Liat Mintz | Methods and systems for annotating biomolecular sequences |
| EP1592791A2 (en) | 2003-02-10 | 2005-11-09 | National Institute of Advanced Industrial Science and Technology | Regulation of gene expression by dna interference |
| US20080248011A1 (en) | 2004-01-27 | 2008-10-09 | Medical And Biological Laboratories Co., Ltd. | Methods for Isolating Monocytes |
| US20070248535A1 (en) | 2005-02-07 | 2007-10-25 | The Trustees Of Columbia University In The City Of New York | Methods to treat or prevent hormone-resistant prostate cancer using siRNA specific for protocadherin-PC, or other inhibitors of protocadherin-PC expression or activity |
| WO2007051077A2 (en) | 2005-10-28 | 2007-05-03 | The Regents Of The University Of California | Methods and compounds for lymphoma cell detection and isolation |
| US20070161031A1 (en) | 2005-12-16 | 2007-07-12 | The Board Of Trustees Of The Leland Stanford Junior University | Functional arrays for high throughput characterization of gene expression regulatory elements |
| EP2021499A4 (en) | 2005-12-16 | 2010-02-17 | Univ Leland Stanford Junior | FUNCTIONAL ARRAYS FOR THE IDENTIFICATION OF ELEMENTS FOR GENE PRESSION REGULATION WITH HIGH THROUGHPUT |
| US7994126B2 (en) | 2006-02-22 | 2011-08-09 | Zhenglun Zhu | Treatment of cellular proliferative disorders with compositions comprising Hom polypeptide (also known as Xom, VENTX2) |
| EP2454372B1 (en) | 2009-07-15 | 2018-10-03 | Zhenglun Zhu | Managing the treatment of inflammatory or autoimmune disorders using hom-1 expression |
| WO2012071513A2 (en) * | 2010-11-24 | 2012-05-31 | Hong Gao | Expanding hematopoietic stem cells |
| WO2012170979A1 (en) * | 2011-06-10 | 2012-12-13 | Zhenglun Zhu | Human homeobox gene ventx and macrophage terminal differentiation and activation, compositions and methods thereof |
| US20150297679A1 (en) | 2012-12-14 | 2015-10-22 | The Brigham And Women's Hospital, Inc. | Methods and assays relating to macrophage differentiation |
| EP2984165B1 (en) * | 2013-04-10 | 2020-12-23 | Zhenglun Zhu | Homeobox transcription factor ventx regulates differentiation and maturation of human dendritic cells |
| US9428748B2 (en) * | 2013-06-17 | 2016-08-30 | Hong Gao | Method of expanding hematopoietic stem cells |
| CA2997912A1 (en) | 2015-09-09 | 2017-03-16 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Genetic engineering of macrophages for immunotherapy |
| AU2016353064B2 (en) | 2015-11-11 | 2022-12-22 | Zhenglun Zhu | Method of modifying macrophage differentiation and immunity |
| AU2017213744B2 (en) | 2016-02-04 | 2023-06-22 | Hong Gao | Treatment and diagnosis of inflammatory disorders |
| EP3601539A4 (en) | 2017-03-28 | 2021-01-13 | Zhenglun Zhu | METHODS OF TREATING NEOPLASIC DISEASES |
-
2017
- 2017-01-31 AU AU2017213744A patent/AU2017213744B2/en active Active
- 2017-01-31 MY MYPI2021007385A patent/MY203831A/en unknown
- 2017-01-31 WO PCT/US2017/015775 patent/WO2017136322A1/en not_active Ceased
- 2017-01-31 MX MX2018009542A patent/MX2018009542A/es unknown
- 2017-01-31 JP JP2018560436A patent/JP2019512018A/ja active Pending
- 2017-01-31 KR KR1020187025087A patent/KR20180109985A/ko not_active Ceased
- 2017-01-31 SG SG11201806636SA patent/SG11201806636SA/en unknown
- 2017-01-31 SG SG10201913129QA patent/SG10201913129QA/en unknown
- 2017-01-31 MY MYPI2018702738A patent/MY194135A/en unknown
- 2017-01-31 CA CA3013898A patent/CA3013898A1/en active Pending
- 2017-01-31 IL IL311968A patent/IL311968A/en unknown
- 2017-01-31 EP EP17748003.5A patent/EP3411479A4/en active Pending
- 2017-01-31 CN CN201780016917.2A patent/CN108779461A/zh active Pending
- 2017-01-31 US US16/075,479 patent/US11268095B2/en active Active
- 2017-01-31 IL IL260987A patent/IL260987B2/en unknown
-
2018
- 2018-08-03 CL CL2018002097A patent/CL2018002097A1/es unknown
- 2018-08-03 MX MX2022010890A patent/MX2022010890A/es unknown
-
2021
- 2021-12-29 CL CL2021003543A patent/CL2021003543A1/es unknown
-
2022
- 2022-02-18 US US17/675,800 patent/US12146138B2/en active Active
- 2022-09-09 JP JP2022143467A patent/JP7635939B2/ja active Active
-
2023
- 2023-09-22 AU AU2023233180A patent/AU2023233180A1/en active Pending
- 2023-10-06 CL CL2023003003A patent/CL2023003003A1/es unknown
-
2024
- 2024-09-06 JP JP2024153550A patent/JP2024170560A/ja active Pending
- 2024-10-17 US US18/918,938 patent/US20250188474A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019512018A5 (enExample) | ||
| Denby et al. | MicroRNA-214 antagonism protects against renal fibrosis | |
| Zhang et al. | MicroRNA-155 contributes to preeclampsia by down-regulating CYR61 | |
| Liu et al. | LncRNA MALAT1/MiR-145 adjusts IL-1β-induced chondrocytes viability and cartilage matrix degradation by regulating ADAMTS5 in human osteoarthritis | |
| Manoury et al. | TIMP-1 is a key factor of fibrogenic response to bleomycin in mouse lung | |
| US11053314B2 (en) | Methods to eliminate cancer stem cells by targeting CD47 | |
| Witalison et al. | Molecular targeting of protein arginine deiminases to suppress colitis and prevent colon cancer | |
| ES2724549T3 (es) | ARN pequeños derivados de RNY como biomarcadores para trastornos relacionados con la aterosclerosis | |
| Ni et al. | CircSLC7A2 protects against osteoarthritis through inhibition of the miR‐4498/TIMP3 axis | |
| US20180110837A1 (en) | Methods and assays relating to macrophage differentiation | |
| Litwin et al. | Gelsolin affects the migratory ability of human colon adenocarcinoma and melanoma cells | |
| Shiba et al. | Differential roles of MMP-9 in early and late stages of dystrophic muscles in a mouse model of Duchenne muscular dystrophy | |
| WO2021231887A1 (en) | Compositions and methods of detection of pre-symptomatic als | |
| WO2019229259A1 (en) | Materials and methods for monitoring the development of resistance of cancers to treatment | |
| CN105987999A (zh) | 用于乳腺癌诊断的联合肿瘤标志物及其试剂盒 | |
| Tan et al. | Circular RNA XRCC5 aggravates glioma progression by activating CLC3/SGK1 axis via recruiting IGF2BP2 | |
| CN114901835B (zh) | 包含mir-335的组合物 | |
| TW202402790A (zh) | 減少呼吸系統感染之方法 | |
| Yang et al. | CircITGA7 regulates malignant phenotypes in bladder cancer cells via targeting miR‐330‐3p/KLF10 axis | |
| CN116270710B (zh) | circRBM33作为靶点在前列腺癌诊断和治疗中的应用 | |
| Kum et al. | Antifibrotic effect via the regulation of transcription factor Sp1 in lung fibrosis | |
| Ma et al. | MMP19 in vascular smooth muscle cells protects against thoracic aortic aneurysm and dissection via the MMP19/Aggrecan/Wnt/β-catenin axis | |
| Xin et al. | Upregulation of MiR-29b contributes to mesenchymal stem cell dysfunction in patients with severe pre-eclampsia | |
| US20160138026A1 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF VprBP-RELATED CANCERS | |
| US20220307030A1 (en) | Uses of synthetic lethal partners for treatment of cancer |